Related Experiment Videos
[Effect of traxanox sodium on inflammatory response]
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|November 1, 1985
Summary
Traxanox showed varied effects on inflammation models, inhibiting some reactions like anaphylactoid responses and delayed type hypersensitivity, but not others. Its potential clinical effectiveness in rheumatoid arthritis warrants further investigation.
Area of Science:
- Immunology
- Pharmacology
Background:
- Inflammation is a complex biological response involving various pathways.
- Understanding the differential effects of novel compounds on distinct inflammatory models is crucial for drug development.
Purpose of the Study:
- To investigate the anti-inflammatory properties of Traxanox across various experimental models.
- To elucidate the mechanism of action of Traxanox by comparing its effects to known anti-inflammatory agents.
Main Methods:
- Evaluation of Traxanox in acute and subacute inflammation models (carrageenan paw edema, UV erythema, pleurisy, granuloma formation).
- Assessment of Traxanox's effect on prostaglandin E2 and slow-reacting substance production.
- Testing Traxanox in adjuvant arthritis and delayed type hypersensitivity models.
- Investigating synergistic effects with hydrocortisone and indomethacin.
Main Results:
- Traxanox was inactive in classic acute/subacute inflammation and prostaglandin E2 production.
- It inhibited anaphylactoid reactions, dextran edema, and delayed type hypersensitivity.
- Synergistic anti-arthritic effects were observed with hydrocortisone and indomethacin when co-administered.
- Pre-treatment with Traxanox dose-dependently suppressed adjuvant arthritis.
Conclusions:
- Traxanox exhibits differential activity against inflammatory responses, targeting specific pathways.
- Its mechanism of action may be similar to D-penicillamine or levamisole.
- Traxanox shows promise for clinical application in treating rheumatoid arthritis.